Meeting abstract
https://doi.org/10.33004/reumatizam-supp-70-1-9
Main challenges in Systemic Lupus Erythematosus in 2023
Laurent Arnaud
Full text: english pdf 1.096 Kb
page 9-9
downloads: 70
cite
APA 6th Edition
Arnaud, L. (2023). Main challenges in Systemic Lupus Erythematosus in 2023. Reumatizam, 70 (Supp 1), 9-9. https://doi.org/10.33004/reumatizam-supp-70-1-9
MLA 8th Edition
Arnaud, Laurent. "Main challenges in Systemic Lupus Erythematosus in 2023." Reumatizam, vol. 70, no. Supp 1, 2023, pp. 9-9. https://doi.org/10.33004/reumatizam-supp-70-1-9. Accessed 17 May 2024.
Chicago 17th Edition
Arnaud, Laurent. "Main challenges in Systemic Lupus Erythematosus in 2023." Reumatizam 70, no. Supp 1 (2023): 9-9. https://doi.org/10.33004/reumatizam-supp-70-1-9
Harvard
Arnaud, L. (2023). 'Main challenges in Systemic Lupus Erythematosus in 2023', Reumatizam, 70(Supp 1), pp. 9-9. https://doi.org/10.33004/reumatizam-supp-70-1-9
Vancouver
Arnaud L. Main challenges in Systemic Lupus Erythematosus in 2023. Reumatizam [Internet]. 2023 [cited 2024 May 17];70(Supp 1):9-9. https://doi.org/10.33004/reumatizam-supp-70-1-9
IEEE
L. Arnaud, "Main challenges in Systemic Lupus Erythematosus in 2023", Reumatizam, vol.70, no. Supp 1, pp. 9-9, 2023. [Online]. https://doi.org/10.33004/reumatizam-supp-70-1-9
Abstract
Keywords
systemic lupus erythematosus, disease activity, damage, remission, glucocorticoids, hydroxychloroquine
Hrčak ID:
309331
URI
https://hrcak.srce.hr/309331
Publication date:
16.10.2023.
Visits: 139
*